NCT05152446

Brief Summary

This study is a multi-center before-after trial design. The object is to observe whether the incidence of central line associated blood stream infection(CLABSI) will tend to descend compared with retrospective electronic medical record data after implementation of an infusion management scheme which comes form " Clinical Practice Guideline on Infusion Therapy in Children " .

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

9 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 26, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 9, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

March 7, 2022

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

November 4, 2024

Status Verified

October 1, 2024

Enrollment Period

2.7 years

First QC Date

November 26, 2021

Last Update Submit

October 31, 2024

Conditions

Keywords

implementation studypediatriceffect evaluationmanagement of infusion nursing

Outcome Measures

Primary Outcomes (1)

  • Incidence of CLABSI

    CLABSI diagnostic criteria requires that a central line is in situ at the time of or within 48 hours; children with a central line have fever (over 38℃), chills, hypotension or mental state changes; there is no alternate source of bloodstream infection. Apart from the above three necessary requirements, CLABSI diagnosis could be accompanied by two positive blood cultures drawn from a peripheral vein and a CVAD, two positive blood cultures drawn from different CVADs, one positive blood culture from a CVAD with a planned specific antimicrobial therapy or common skin contamination bacteria cultured (eg. Coagulase-negative Staphylococci, diphtheroids, Bacillus or Micrococcus). Incidence of CLABSI = (case numbers of CLABSI)/(Catheter Days per Month)×1000‰.

    During the 6-month implementation

Secondary Outcomes (3)

  • Changes of Inspection rate of suspected CLABSI samples

    From baseline to the end of the 6-month implementation

  • Incidece of infiltration (of Grade2 or higher) and/or extravasation

    During the 6-month implementation

  • Changes of the scores of readiness of internal context

    From baseline to the end of the 6-month implementation

Study Arms (1)

Infusion management scheme

EXPERIMENTAL

To implement infusion management scheme, then observe the continuous changes.

Other: Infusion management scheme

Interventions

* To set up a pediatric intravenous infusion team; * To form standardized procedures by carrying out a quality improvement program in collecting and sending samples for inspection once suspected CLABSI occurs (1 month for training and 3 months for continuous improvement ); providing infusion training curriculums to nurses in forms of lectures, group discussions, operation demonstrations, and scenario simulations, holding practice review meeting with them; providing elements to caregivers of educational leaflet, nurse-provided education during patients' infusion therapy( 6-month implementation); * To observe the continued daily infusion practice in 6 months.

Infusion management scheme

Eligibility Criteria

Age1 Day - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • A tertiary children's hospital with more than 300 beds
  • The vice president in charge of nursing affairs, the director of nursing department and the director of hospital infection control department all agree in participating in this study with written permission, which include total acceptance of infusion management scheme and outcome indicators report as required
  • To obtain the approval from Ethics Committee of the hospital
  • Hospitalized children aged 0\~18 years
  • Catheterization and maintenance in the same center
  • The indwelling time is longer than 48h

You may not qualify if:

  • The vice president in charge of nursing affairs or the director of nursing department inform the researcher to withdraw from this study with written form and should clear reasons
  • The number of cases for suspected CLABSI sample actually submitted for inspection / The number of cases for suspected CLABSI sample should submitted for inspection\<0.9
  • The awareness rate of infusion management scheme in clinical nurses is less than 90% and the qualification rate of the practice examination in clinical nurses is less than90% during inspection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Anhui Provincial Children's Hospital

Hefei, Anhui, China

Location

Xiamen Children's Hospital

Xiamen, Fujian, China

Location

First Affiliated Hospital of Guangxi Medical University

Nanning, Guangxi, China

Location

Tongji Hospital

Wuhan, Hubei, China

Location

Hunan Children's Hospital

Changsha, Hunan, China

Location

Qidong Women's and Children's Health

Qidong, Jiangsu, China

Location

Dalian women and children's medical group

Dalian, Liaoning, China

Location

Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, 201102, China

Location

Chengdu Women's and Children's Central Hospital

Chengdu, Sichuan, China

Location

MeSH Terms

Conditions

Infections

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 26, 2021

First Posted

December 9, 2021

Study Start

March 7, 2022

Primary Completion

November 1, 2024

Study Completion

November 1, 2024

Last Updated

November 4, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations